EX-99.26 27 d20922dex9926.htm EX-99.26 EX-99.26

IMMUNOPRECISE ANTIBODIES LTD.

 

 

 

  

Exhibit 99.26

 

 

LOGO

  

 

Security Class

 

Holder Account Number

 

                   
      

Fold

Form of Proxy - Annual General Meeting to be held on Friday, November 22, 2019  
This Form of Proxy is solicited by and on behalf of Management.  
Notes to proxy  
1.      Every holder has the right to appoint some other person or company of their choice, who need not be a holder, to attend and act on their behalf at the meeting or any adjournment or postponement thereof. If you wish to appoint a person or company other than the persons whose names are printed herein, please insert the name of your chosen proxyholder in the space provided (see reverse).  
2.      If the securities are registered in the name of more than one owner (for example, joint ownership, trustees, executors, etc.), then all those registered should sign this proxy. If you are voting on behalf of a corporation or another individual you must sign this proxy with signing capacity stated, and you may be required to provide documentation evidencing your power to sign this proxy.  
3.      This proxy should be signed in the exact manner as the name(s) appear(s) on the proxy.  
4.      If this proxy is not dated, it will be deemed to bear the date on which it is mailed by Management to the holder.  
5.      The securities represented by this proxy will be voted as directed by the holder, however, if such a direction is not made in respect of any matter, this proxy will be voted as recommended by Management.  
6.      The securities represented by this proxy will be voted in favour or withheld from voting or voted against each of the matters described herein, as applicable, in accordance with the instructions of the holder, on any ballot that may be called for and, if the holder has specified a choice with respect to any matter to be acted on, the securities will be voted accordingly.  
7.      This proxy confers discretionary authority in respect of amendments or variations to matters identified in the Notice of Meeting or other matters that may properly come before the meeting or any adjournment or postponement thereof.  

 

        

 

8.

    

 

This proxy should be read in conjunction with the accompanying documentation provided by Management.

  Fold
 

Proxies submitted must be received by 10:00 am, Pacific Time, on Wednesday, November 20, 2019

VOTE USING THE TELEPHONE OR INTERNET 24 HOURS A DAY 7 DAYS A WEEK!

 

LOGO

If you vote by telephone or the Internet, DO NOT mail back this proxy.

Voting by mail may be the only method for securities held in the name of a corporation or securities being voted on behalf of another individual.

Voting by mail or by Internet are the only methods by which a holder may appoint a person as proxyholder other than the Management nominees named on the reverse of this proxy. Instead of mailing this proxy, you may choose one of the two voting methods outlined above to vote this proxy.

To vote by telephone or the Internet, you will need to provide your CONTROL NUMBER listed below.

CONTROL NUMBER


LOGO

Appointment of Proxyholder
I/We being holder(s) of Immunoprecise Antibodies Ltd. hereby appoint (s): Jennifer Bath, an officer and director of the Company, or failing her, James Kuo, a director of the Company, or failing him, Lisa Helbling, an officer of the Company, or failing her, Paul Andreola, a director of the Company
OR
Print the name of the person you are appointing if this person is someone other than the Chairman of the Meeting.
as my/our proxyholder with full power of substitution and to attend, act and to vote for and on behalf of the shareholder in accordance with the following direction (or if no directions have been given, as the proxyholder sees fit) and all other matters that may properly come before the Annual General Meeting of shareholders of Immunoprecise Antibodies Ltd. to be held at Northwest Law Group Barrister and Solicitors, Suite 704, 595 Howe Street, Vancouver, BC on Friday, November 22, 2019 at 10:00 am, Pacific Time and at any adjournment or postponement thereof.
VOTING RECOMMENDATIONS ARE INDICATED BY HIGHLIGHTED TEXT OVER THE BOXES.

 

For
Against
1. Number of Directors
To Set the Number of Directors at seven (7).
————  
2. Election of Directors
Fold
For
Withhold
For
Withhold
For
Withhold
01. Jennifer Bath
02. James Kuo
03. Greg Smith
04. Robert Beecroft
05. Robert Burke
06. Paul Andreola
07. Brian Lundstrom
For
Withhold
3. Appointment of Auditors
Appointment of Crowe MacKay LLP as Auditors of the Company for the ensuing year and authorizing the Directors to fix their remuneration.
For
Against
4. Stock Option Plan
To consider and, if thought fit, to pass an ordinary resolution approving and ratifying the Company’s currently implemented Stock Option Plan, as
more fully set out in the accompanying Information Circular.
For
Against
5. Shareholder Rights Plan
————  
Fold
To consider, and if thought fit, to pass an ordinary resolution, the full text of which is set forth in the accompanying Information Circular, approving
and ratifying the Company’s Shareholder Rights Plan, as more particularly described in the accompanying Information Circular.
Authorized Signature(s)—This section must be completed for your
Signature(s)
Date
instructions to be executed.
I/We authorize you to act in accordance with my/our instructions set out above. I/We hereby
revoke any proxy previously given with respect to the Meeting. If no voting instructions are
indicated above, this Proxy will be voted as recommended by Management.
Interim Financial Statements - Mark this box if you would
Annual Financial Statements - Mark this box if you would
like to receive Interim Financial Statements and
like to receive the Annual Financial Statements and
accompanying Management’s Discussion and Analysis by
accompanying Management’s Discussion and Analysis by
mail.
mail.
If you are not mailing back your proxy, you may register online to receive the above financial report(s) by mail at www.computershare.com/mailinglist.
T L R Q 3 0 1 0 5 7 A R 1